Studies on Tissue and Cellular Distribution of Indoleamine 2,3-Dioxygenase 2: The Absence of IDO1 Upregulates IDO2 Expression in the Epididymis

被引:64
|
作者
Fukunaga, Masakazu [1 ,2 ]
Yamamoto, Yasuko [1 ,2 ]
Kawasoe, Misaki [1 ,2 ]
Arioka, Yuko [1 ,2 ]
Murakami, Yuki [1 ,2 ]
Hoshi, Masato [3 ]
Saito, Kuniaki [1 ,2 ]
机构
[1] Kyoto Univ, Grad Sch Med, Kyoto 6068507, Japan
[2] Kyoto Univ, Fac Med, Kyoto 6068507, Japan
[3] Suzuka Univ Med Sci, Suzuka, Japan
关键词
indoleamine; 2; 3-dioxygenase; 1; epididymis;
D O I
10.1369/0022155412458926
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Indoleamine 2,3-dioxygenase 1 (IDO1) catabolizes tryptophan to kynurenine at the first step of tryptophan metabolism. Recently, in addition to IDO1, a new isoform called IDO2 was identified. In this study, we examined the tissue expression pattern of IDO2 mRNA and the cellular localization of expressed IDO2 protein in mice. IDO1 mRNA expression was observed in the colon and epididymis, whereas IDO2 mRNA expression was found in the cerebral cortex, liver, kidney, and epididymis. Immunohistochemical analysis revealed that IDO2 protein was exclusively expressed on the hepatocytes, interlobular bile ducts, neuronal cells of the cerebrum cortex, Purkinje cells of the cerebellum cortex, lamina epithelialis, proximal convoluted tubule, and the collecting tubule of the kidney. In the epididymis, IDO1 protein expression was restricted to the caput, whereas IDO2 protein expression was observed on the caput, corpus, and cauda. Both IDO proteins were expressed on the caput, but both showed a different protein expression pattern in the segments. Immunohistochemical analysis in IDO1-/- mouse epididymis showed that IDO2 protein was extensively upregulated due to the loss of IDO1 expression. (J Histochem Cytochem 60:854-860, 2012)
引用
收藏
页码:854 / 860
页数:7
相关论文
共 50 条
  • [31] Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO)
    Zhang, Shengnan
    Guo, Leilei
    Yang, Dan
    Xing, Zikang
    Li, Weirui
    Kuang, Chunxiang
    Yang, Qing
    BIOORGANIC CHEMISTRY, 2020, 104
  • [32] Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease
    Fatokun, Amos A.
    Hunt, Nicholas H.
    Ball, Helen J.
    AMINO ACIDS, 2013, 45 (06) : 1319 - 1329
  • [33] Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease
    Amos A. Fatokun
    Nicholas H. Hunt
    Helen J. Ball
    Amino Acids, 2013, 45 : 1319 - 1329
  • [34] A molecular docking strategy for identifying fragment inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1)
    Fung, Simon
    Flanagan, Jack U.
    Squire, Christopher J.
    Palmer, Brian D.
    Ching, Lai-Ming
    CANCER RESEARCH, 2014, 74 (19)
  • [35] Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process
    Salminen, Antero
    AGEING RESEARCH REVIEWS, 2022, 75
  • [36] Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis
    Merlo, Lauren M. F.
    Grabler, Samantha
    DuHadaway, James B.
    Pigott, Elizabeth
    Manley, Kaylend
    Prendergast, George C.
    Laury-Kleintop, Lisa D.
    Mandik-Nayak, Laura
    CLINICAL IMMUNOLOGY, 2017, 179 : 8 - 16
  • [37] The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy
    von Bubnoff, D.
    Bieber, T.
    ALLERGY, 2012, 67 (06) : 718 - 725
  • [38] A theranostic probe of indoleamine 2,3-dioxygenase 1 (IDO1) for small molecule cancer immunotherapy
    Wu, Ying
    Zhang, Yanhui
    Chen, Xi
    Hu, Yulu
    Dong, Guoqiang
    Guo, Yuan
    Sheng, Chunquan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 213
  • [39] Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice
    Aslamkhan, Amy G.
    Xu, Qiuwei
    Loughlin, Amy
    Vu, Heather
    Pacchione, Stephen
    Bhatt, Bhavana
    Garfinkel, Ivy
    Styring, Tara Grady
    LaFranco-Scheuch, Lisa
    Pearson, Kara
    Reynolds, Spencer
    Li, Nianyu
    Zhou, Heather
    Miller, J. Richard
    Solban, Nicolas
    Bass, Alan
    Glaab, Warren E.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 406
  • [40] Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold
    Brant, Michael G.
    Goodwin-Tindall, Jake
    Stover, Kurt R.
    Stafford, Paul M.
    Wu, Fan
    Meek, Autumn R.
    Schiavini, Paolo
    Wohnig, Stephanie
    Weaver, Donald F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (02): : 131 - 136